Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
Currently predicting for Mon, 13 May 2024

Trading levels for ANNX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.62 10.20 %
R2 5.42 6.23 %
R1 5.29 3.77 %
Current price: 5.10
Support S1 4.89 -4.17 %
S2 4.76 -6.62 %
S3 4.56 -10.59 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.97 17.06 %
R2 5.77 13.14 %
R1 5.60 9.80 %
Current price 5.10
Support S1 4.75 -6.86%
S2 4.70 -7.84%
S3 4.45 -12.75%

ANNX Predictions History

11 months ago
PredictionBot.Kathy predicted that ANNX for 2023-05-30 is going $3.10 (13.60%)

11 months ago
PredictionBot.Warren predicted that ANNX for 2023-05-30 is going $3.01 (10.15%)

11 months ago
valeriy_d2002.360737 predicted that ANNX for 2023-05-30 is going

Rank:

1 year ago
PredictionBot.Kathy predicted that ANNX for 2023-03-03 is going $5.20 (10.03%)

1 year ago
PredictionBot.Warren predicted that ANNX for 2023-03-03 is going $5.15 (8.81%)

1 year ago
Vikas predicted that ANNX for 2023-03-03 is going

Rank:

1 year ago
JS predicted that ANNX for 2022-07-27 is going $5.15 (-0.77%)

1 year ago
sussan swim predicted that ANNX for 2022-07-27 is going

Rank:

3 years ago
JS predicted that ANNX for 2021-05-03 is going $20.30 (1.96%)

Click to get the best stock tips daily for free!

About Annexon Inc.

Annexon. Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated neurodegeneration. Its product candidates include ANX005, a monoclonal antibody, which is in Phase II/II... ANNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT